Research Overview
Semax — neurotrophic and monoaminergic research
Semax was derived from ACTH(4–10) by adding Pro-Gly-Pro to the C-terminus, a modification that eliminates adrenal stimulation while extending the peptide's half-life in plasma. Rodent studies have reported increased BDNF and NGF expression, changes in TrkB receptor signalling and altered dopaminergic and serotonergic turnover in the hippocampus and frontal cortex after administration. Behavioural work has examined attention, learning-acquisition and memory-retention tasks, and ischaemia models have been used to look at neuronal survival endpoints. Much of the primary literature is Russian-language and heterogeneous in design.
Selank — GABAergic and stress-response research
Why the two are studied together
- Complementary mechanisms — neurotrophic signalling versus inhibitory and stress-axis modulation.
- Similar physical chemistry — both are small, water-soluble heptapeptides sharing the Pro-Gly-Pro motif, so they co-lyophilize and reconstitute cleanly together.
- Overlapping model systems — attention, memory and stress paradigms often measure endpoints relevant to both peptides.
What a blend does and does not resolve
A fixed 1:1 vial removes weighing error between two components and simplifies handling, but it also fixes the ratio. Studies designed to separate the contribution of each peptide, or to vary their proportion, need the single-compound vials rather than the blend. Investigators frequently run the blend alongside Semax-alone and Selank-alone arms for this reason.